PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Zai Lab Ltd (9688.HK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

KYG9887T1168

Sector

Healthcare

Highlights

Market Cap

HK$30.05B

EPS (TTM)

-HK$0.25

Total Revenue (TTM)

HK$398.99M

Gross Profit (TTM)

HK$251.13M

Year Range

HK$10.56 - HK$30.90

Target Price

HK$38.01

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of HK$10,000 in Zai Lab Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-50.00%0.00%50.00%100.00%OctoberNovemberDecember2025FebruaryMarch
-54.51%
69.61%
9688.HK (Zai Lab Ltd)
Benchmark (^GSPC)

Returns By Period

Zai Lab Ltd had a return of 32.14% year-to-date (YTD) and 106.78% in the last 12 months.


9688.HK

YTD

32.14%

1M

11.00%

6M

68.59%

1Y

106.78%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

-3.64%

1M

-7.76%

6M

-0.61%

1Y

8.13%

5Y*

19.77%

10Y*

10.51%

*Annualized

Monthly Returns

The table below presents the monthly returns of 9688.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-0.48%27.27%32.14%
2024-21.67%1.19%-24.30%0.78%12.62%-8.47%11.19%2.28%24.80%25.66%-6.07%-6.46%-2.33%
202331.30%-13.00%-7.30%4.61%-5.14%-18.76%17.38%-15.01%-9.59%4.75%7.11%1.18%-12.60%
2022-31.90%18.51%-11.97%-8.34%-24.43%7.43%19.81%10.61%-22.71%-34.01%50.44%-9.56%-51.38%
202115.67%-7.36%-7.13%25.75%6.72%-1.23%-22.43%3.97%-23.73%-3.16%-30.83%-9.96%-51.06%
20205.08%0.62%28.99%24.28%69.51%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 83, 9688.HK is among the top 17% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of 9688.HK is 8383
Overall Rank
The Sharpe Ratio Rank of 9688.HK is 8787
Sharpe Ratio Rank
The Sortino Ratio Rank of 9688.HK is 8383
Sortino Ratio Rank
The Omega Ratio Rank of 9688.HK is 8181
Omega Ratio Rank
The Calmar Ratio Rank of 9688.HK is 8080
Calmar Ratio Rank
The Martin Ratio Rank of 9688.HK is 8585
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Zai Lab Ltd (9688.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for 9688.HK, currently valued at 1.31, compared to the broader market-2.00-1.000.001.002.003.001.310.69
The chart of Sortino ratio for 9688.HK, currently valued at 2.01, compared to the broader market-4.00-2.000.002.004.002.010.99
The chart of Omega ratio for 9688.HK, currently valued at 1.25, compared to the broader market0.501.001.502.001.251.13
The chart of Calmar ratio for 9688.HK, currently valued at 0.88, compared to the broader market0.001.002.003.004.005.000.880.93
The chart of Martin ratio for 9688.HK, currently valued at 5.26, compared to the broader market0.005.0010.0015.0020.005.263.33
9688.HK
^GSPC

The current Zai Lab Ltd Sharpe ratio is 1.31. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Zai Lab Ltd with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00OctoberNovemberDecember2025FebruaryMarch
1.31
0.64
9688.HK (Zai Lab Ltd)
Benchmark (^GSPC)

Dividends

Dividend History


Zai Lab Ltd doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2025FebruaryMarch
-81.55%
-7.80%
9688.HK (Zai Lab Ltd)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Zai Lab Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Zai Lab Ltd was 92.94%, occurring on Apr 18, 2024. The portfolio has not yet recovered.

The current Zai Lab Ltd drawdown is 81.55%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-92.94%Jan 22, 2021795Apr 18, 2024
-13.09%Oct 14, 202014Nov 3, 20207Nov 12, 202021
-4.53%Dec 2, 20207Dec 10, 20204Dec 16, 202011
-3.35%Jan 5, 20213Jan 7, 20211Jan 8, 20214
-3.26%Dec 28, 20203Dec 30, 20201Dec 31, 20204

Volatility

Volatility Chart

The current Zai Lab Ltd volatility is 18.95%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%OctoberNovemberDecember2025FebruaryMarch
18.95%
5.88%
9688.HK (Zai Lab Ltd)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Zai Lab Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Zai Lab Ltd.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab